बेल्जियम - फ़्रेंच - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - maléate de timolol 6,83 mg/ml - eq. timolol 5 mg/ml; chlorhydrate de dorzolamide 22,26 mg/ml - eq. dorzolamide 20 mg/ml - collyre en solution - 20 mg/ml - 5 mg/ml - maléate de timolol 6.83 mg/ml; chlorhydrate de dorzolamide 22.26 mg/ml - timolol, combinations

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg); dorzolamide hydrochloride, quantity: 22.3 mg/ml (equivalent: dorzolamide, qty 20 mg) - eye drops, solution - excipient ingredients: mannitol; sodium citrate dihydrate; water for injections; benzalkonium chloride; sodium hydroxide; hyetellose - dorzolamide/timolol 20/5 eye drops are indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol maleate ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol maleate is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease (see warnings); (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure (see warnings); (7) cardiogenic shock; or (8) hypersensitivity to any component of this product.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol maleate ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol maleate ophthalmic solution is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease (see warnings); (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure (see warnings); (7) cardiogenic shock; or (8) hypersensitivity to any component of this product.

कनाडा - फ़्रेंच - Health Canada

sandoz canada incorporated - timolol (maléate de timolol) - solution (à libération prolongée) - 0.25% - timolol (maléate de timolol) 0.25% - beta-adrenergic agents

कनाडा - फ़्रेंच - Health Canada

sandoz canada incorporated - timolol (maléate de timolol) - solution (à libération prolongée) - 0.5% - timolol (maléate de timolol) 0.5% - beta-adrenergic agents

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - latanoprost,timolol maleate -

फ़्रांस - फ़्रेंच - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

teva sante - dorzolamide 20 mg sous forme de : chlorhydrate de dorzolamide 22; timolol 5 mg sous forme de : maléate de timolol 6 - collyre - 20 mg - pour 1 ml > dorzolamide 20 mg sous forme de : chlorhydrate de dorzolamide 22,26 mg > timolol 5 mg sous forme de : maléate de timolol 6,83 mg - antiglaucomateux et myotiques - classe pharmacothérapeutique - code atc : antiglaucomateux et myotiques, bêta-bloquants, timolol en association - s01ed51dorzolamide/timolol teva contient deux médicaments : dorzolamide et timolol.le dorzolamide appartient à une classe de médicaments appelés « inhibiteurs de l'anhydrase carbonique ». le timolol appartient à une classe de médicaments appelés « bêta-bloquants ». ces deux médicaments réduisent la tension dans l'œil de façons différentes.dorzolamide/timolol teva est indiqué pour faire baisser la pression intra-oculaire élevée chez les patients présentant un glaucome lorsqu'un collyre bêta-bloquant administré seul est insuffisant.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - latanoprost,timolol maleate -

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - timolol maleate, quantity: 3.4 mg/ml (equivalent: timolol, qty 2.5 mg/ml) - eye drops, solution - excipient ingredients: sodium hydroxide; dibasic sodium phosphate dodecahydrate; benzalkonium chloride; water for injections; monobasic sodium phosphate dihydrate - timolol ophthalmic solution is indicated for the reduction of elevated intraocular pressure.,in clinical trials it has been shown to reduce intraocular pressure in:,patients with ocular hypertension,patients with chronic open-angle glaucoma,aphakic patients with glaucoma.